From empiricism to rational design: a personal perspective of the evolution of vaccine development

被引：150

作者：

De Gregorio, Ennio ^{[1
]}

Rappuoli, Rino ^{[1
]}

机构：

[1] Novartis Vaccines, I-53100 Siena, Italy

来源：

NATURE REVIEWS IMMUNOLOGY | 2014年 / 14卷 / 07期

关键词：

PNEUMOCOCCAL CONJUGATE VACCINE; CELL-MEDIATED-IMMUNITY; YELLOW-FEVER VACCINE; HEPATITIS-B-VACCINE; HIV-1; VACCINE; VIRUS-VACCINE; HAEMOPHILUS-INFLUENZAE; CANDIDATE ANTIGENS; CONTROLLED-TRIAL; ADJUVANT SYSTEM;

D O I：

10.1038/nri3694

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vaccination, which is the most effective medical intervention that has ever been introduced, originated from the observation that individuals who survived a plague or smallpox would not get the disease twice. To mimic the protective effects of natural infection, Jenner-and later Pasteur-inoculated individuals with attenuated or killed disease-causing agents. This empirical approach inspired a century of vaccine development and the effective prophylaxis of many infectious diseases. From the 1980s, several waves of new technologies have enabled the development of novel vaccines that would not have been possible using the empirical approach. The technological revolution in the field of vaccination is now continuing, and it is delivering novel and safer vaccines. In this Timeline article, we provide our views on the transition from empiricism to rational vaccine design.

引用

页码：505 / 514

页数：10

共 113 条

[11]

Austrian R, 1976, Trans Assoc Am Physicians, V89, P184

[12]

Austrian R, 1996, VACCINIA, VACCINATION, VACCINOLOGY, P127

[13] Chemo-immunological studies on conjugated carbohydrate-proteins II. Immunological specificity of synthetic sugar-protein antigens [J].

Avery, OT ;

Goebel, WF .

JOURNAL OF EXPERIMENTAL MEDICINE, 1929, 50 (04) :533-550

[14] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [J].

Barouch, Dan H. ;

Whitney, James B. ;

Moldt, Brian ;

Klein, Florian ;

Oliveira, Thiago Y. ;

Liu, Jinyan ;

Stephenson, Kathryn E. ;

Chang, Hui-Wen ;

Shekhar, Karthik ;

Gupta, Sanjana ;

Nkolola, Joseph P. ;

Seaman, Michael S. ;

Smith, Kaitlin M. ;

Borducchi, Erica N. ;

Cabral, Crystal ;

Smith, Jeffrey Y. ;

Blackmore, Stephen ;

Sanisetty, Srisowmya ;

Perry, James R. ;

Beck, Matthew ;

Lewis, Mark G. ;

Rinaldi, William ;

Chakraborty, Arup K. ;

Poignard, Pascal ;

Nussenzweig, Michel C. ;

Burton, Dennis R. .

NATURE, 2013, 503 (7475) :224-+

[15] A Cell Culture-Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults [J].

Bart, Stephan A. ;

Hohenboken, Matthew ;

Della Cioppa, Giovanni ;

Narasimhan, Vas ;

Dormitzer, Philip R. ;

Kanesa-thasan, Niranjan .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (234)

[16]

Behring E.A., 1890, Deutsche Medzinische Wochenschrift, V16, P1145

[17] Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case [J].

Bensi, Giuliano ;

Mora, Marirosa ;

Tuscano, Giovanna ;

Biagini, Massimiliano ;

Chiarot, Emiliano ;

Bombaci, Mauro ;

Capo, Sabrina ;

Falugi, Fabiana ;

Manetti, Andrea G. O. ;

Donato, Paolo ;

Swennen, Erwin ;

Gallotta, Marilena ;

Garibaldi, Manuela ;

Pinto, Vittoria ;

Chiappini, Nico ;

Musser, James M. ;

Janulczyk, Robert ;

Mariani, Massimo ;

Scarselli, Maria ;

Telford, John L. ;

Grifantini, Renata ;

Norais, Nathalie ;

Margarit, Immaculada ;

Grandi, Guido .

MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (06)

[18] Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis [J].

Bertholet, Sylvie ;

Ireton, Gregory C. ;

Kahn, Maria ;

Guderian, Jeffrey ;

Mohamath, Raodoh ;

Stride, Nicole ;

Laughlin, Elsa M. ;

Baldwin, Susan L. ;

Vedvick, Thomas S. ;

Coler, Rhea N. ;

Reed, Steven G. .

JOURNAL OF IMMUNOLOGY, 2008, 181 (11) :7948-7957

[19] lmmunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials [J].

Bhutta, Zulfiqar A. ;

Capeding, Maria Rosario ;

Bavdekar, Ashish ;

Marchetti, Elisa ;

Ariff, Shabina ;

Soofi, Sajid B. ;

Anemona, Alessandra ;

Habib, Muhammad A. ;

Alberto, Edison ;

Juvekar, Sanjay ;

Khan, Rana M. Qasim ;

Marhaba, Rachid ;

Ali, Noshad ;

Malubay, Nelia ;

Kawade, Anand ;

Saul, Allan ;

Martin, Laura B. ;

Podda, Audino .

LANCET INFECTIOUS DISEASES, 2014, 14 (02) :119-129

[20] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].

Black, S ;

Shinefield, H ;

Fireman, B ;

Lewis, E ;

Ray, P ;

Hansen, JR ;

Elvin, L ;

Ensor, KM ;

Hackell, J ;

Siber, G ;

Malinoski, F ;

Madore, D ;

Chang, I ;

Kohberger, R ;

Watson, W ;

Austrian, R ;

Edwards, K .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195

← 1 2 3 4 5 6 7 8 9 10 →